Zealand Pharma Announces Financial Results for the Full Year 2023
27 févr. 2024 01h00 HE
|
Zealand Pharma
Company announcement - No. 9 / 2024 Zealand Pharma Announces Financial Results for the Full Year 2023 Significant progress delivered across our obesity and rare disease assets while building a...
Peptide Therapeutics Market Size Worth USD 75.92 Billion in 2032 | Emergen Research
17 janv. 2024 12h58 HE
|
Emergen Research
Vancouver, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The global peptide therapeutics market size was USD 42.70 Billion in 2022 and is expected to register a revenue CAGR of 6.0% during the forecast period....
Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th
02 janv. 2024 02h00 HE
|
Zealand Pharma
Press Release – No. 1 / 2024 Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th Copenhagen, Denmark, January 2, 2024 – Zealand...
Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek
17 oct. 2023 02h00 HE
|
Zealand Pharma
Press release – No. 13 / 2023 Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek Copenhagen, Denmark, October 17, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no....
[Size Report] Peptide Therapeutics Market (9.2% CAGR by 2027) to Hit $50 Billion, Globally, with Hybrid Technology Segment Driving Growth During 2020-2027 | The Insight Partners
12 juil. 2023 08h53 HE
|
The Insight Partners
Pune, India, July 12, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Peptide Therapeutics Market Size Report and Forecast to 2027 - COVID-19 Impact and...
Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
03 juil. 2023 06h01 HE
|
Zealand Pharma
Company announcement – No. 27 / 2023 Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396 Doses of 0.6 and 1.2 mg ZP8396...
Global Peptide Therapeutics Market on the Rise with Advancements in Biotechnology and Increased Demand for Targeted Therapies
12 juin 2023 21h30 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, June 12, 2023 (GLOBE NEWSWIRE) -- The peptide therapeutics market is expanding due to the rising prevalence of some metabolic disorders such as genetic disorders, organ dysfunction...
Peptide Therapeutics Market Size to Hit USD 91.25 Bn by 2031 | TMR Study
14 avr. 2023 15h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 15, 2023 (GLOBE NEWSWIRE) -- The worldwide market for peptide therapeutics is forecasted to augment at a CAGR of 8.8% from 2022 to 2031. According to...
MBX Biosciences to Participate in the SVB Securities Global Biopharma Conference
24 janv. 2023 08h00 HE
|
MBX Biosciences, Inc.
CARMEL, Ind., Jan. 24, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
MBX Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
05 janv. 2023 08h00 HE
|
MBX Biosciences, Inc.
CARMEL, Ind., Jan. 05, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...